Stay updated on Organon & Co. Press Releases

Sign up to get notified when there's something new on the Organon & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Organon & Co. Press Releases page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Organon has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference and received FDA approval for VTAMA® cream for atopic dermatitis, while previous updates regarding a licensing agreement and positive study results for OG-8276A have been removed.
    Difference
    89%
    Check dated 2024-12-22T03:32:24.000Z thumbnail image
  5. Check
    31 days ago
    No Change Detected
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has added new content, while the 'Cookie Preferences' section has been removed.
    Difference
    0.5%
    Check dated 2024-12-07T17:13:15.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has added new content, while the 'Cookie Preferences' section has been removed.
    Difference
    0.5%
    Check dated 2024-11-30T15:33:57.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The website has added a 'Cookie Preferences' section while removing a significant number of menu items, including product listings, corporate governance details, and various regional site links.
    Difference
    52%
    Check dated 2024-11-23T05:13:05.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The website has added extensive new sections including product information, leadership details, and regional directories, while removing a recent announcement about a new executive appointment and updating the FDA review status for VTAMA®.
    Difference
    100%
    Check dated 2024-11-08T18:50:47.000Z thumbnail image
  10. Check
    75 days ago
    Change Detected
    Summary
    Organon has reported its third quarter results for 2024 and announced the acceptance of a BLA for its biosimilar candidate HLX14, while also completing the acquisition of Dermavant, which includes the innovative therapy VTAMA®.
    Difference
    74%
    Check dated 2024-11-01T11:22:56.000Z thumbnail image

Stay in the know with updates to Organon & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Organon & Co. Press Releases page.